Travere Therapeutics Inc (NAS:TVTX)
$ 65.7 +1.26 (+1.96%) Market Cap: 6.19 Bil Enterprise Value: 6.32 Bil PE Ratio: 0 PB Ratio: 252.71 GF Score: 61/100

Q1 2026 Travere Therapeutics Inc Earnings Call Transcript

May 04, 2026 / 08:30PM GMT
Release Date Price: $44.91 (+1.79%)
Operator

Hello, and welcome to Travere Therapeutics first quarter 2026 financial results conference call. Today's call is being recorded. At this time, I would like to turn the conference call over to Nivi Nehra, Vice President, Corporate Communications and Investor Relations. Please go ahead, Nivi.

Nivi Nehra
Travere Therapeutics Inc - Vice President - Corporate Communications & Investor Relations

Thank you, operator. Good afternoon, and welcome to Travere Therapeuticsâ first quarter 2026 financial results and corporate update call. Thank you all for joining.

Todayâs call will be led by Dr. Eric Dube, our President and Chief Executive Officer. Eric will be joined in the prepared remarks by Dr. Jula Inrig, our Chief Medical Officer; Peter Heerma, our Chief Commercial Officer; and Chris Cline, our Chief Financial Officer. Dr. Bill Rote, our Chief Research Officer, will join us for the Q&A.

Before we begin, Iâd like to remind everyone that statements made during this call regarding matters that are not historical facts are forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot